Annual Cash & Cash Equivalents
$2.29 M
-$15.44 M-87.09%
31 December 2023
Summary:
Enveric Biosciences annual cash & cash equivalents is currently $2.29 million, with the most recent change of -$15.44 million (-87.09%) on 31 December 2023. During the last 3 years, it has risen by +$709.50 thousand (+44.95%). ENVB annual cash & cash equivalents is now -87.09% below its all-time high of $17.72 million, reached on 31 December 2022.ENVB Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$3.11 M
-$390.90 K-11.16%
30 September 2024
Summary:
Enveric Biosciences quarterly cash and cash equivalents is currently $3.11 million, with the most recent change of -$390.90 thousand (-11.16%) on 30 September 2024. Over the past year, it has dropped by -$1.15 million (-27.07%). ENVB quarterly cash and cash equivalents is now -86.27% below its all-time high of $22.66 million, reached on 31 March 2021.ENVB Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ENVB Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -87.1% | -27.1% |
| 3 y3 years | +45.0% | -85.5% |
| 5 y5 years | +66.8% | +522.7% |
ENVB Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -87.1% | +45.0% | -85.7% | +36.0% |
| 5 y | 5 years | -87.1% | +430.4% | -86.3% | +621.3% |
| alltime | all time | -87.1% | >+9999.0% | -86.3% | >+9999.0% |
Enveric Biosciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $3.11 M(-11.2%) |
| June 2024 | - | $3.50 M(-44.9%) |
| Mar 2024 | - | $6.36 M(+177.8%) |
| Dec 2023 | $2.29 M(-87.1%) | $2.29 M(-46.4%) |
| Sept 2023 | - | $4.27 M(-39.7%) |
| June 2023 | - | $7.08 M(-43.6%) |
| Mar 2023 | - | $12.56 M(-29.1%) |
| Dec 2022 | $17.72 M(+2.1%) | $17.72 M(-16.4%) |
| Sept 2022 | - | $21.20 M(+17.7%) |
| June 2022 | - | $18.01 M(-17.0%) |
| Mar 2022 | - | $21.69 M(+25.0%) |
| Dec 2021 | $17.36 M(+999.5%) | $17.36 M(-19.1%) |
| Sept 2021 | - | $21.45 M(+4.0%) |
| June 2021 | - | $20.62 M(-9.0%) |
| Mar 2021 | - | $22.66 M(+1335.4%) |
| Dec 2020 | $1.58 M(+265.9%) | $1.58 M(-44.4%) |
| Sept 2020 | - | $2.84 M(+36.0%) |
| June 2020 | - | $2.09 M(+64.7%) |
| Mar 2020 | - | $1.27 M(+193.8%) |
| Dec 2019 | $431.40 K(-68.5%) | $431.40 K(-13.7%) |
| Sept 2019 | - | $499.70 K(-68.8%) |
| June 2019 | - | $1.60 M(-7.1%) |
| Mar 2019 | - | $1.72 M(+25.7%) |
| Dec 2018 | $1.37 M(-71.9%) | $1.37 M(-33.6%) |
| Sept 2018 | - | $2.06 M(+125.5%) |
| June 2018 | - | $915.10 K(-48.1%) |
| Mar 2018 | - | $1.76 M(-63.9%) |
| Dec 2017 | $4.88 M(+253.8%) | $4.88 M(+478.4%) |
| Sept 2017 | - | $844.10 K(-18.9%) |
| June 2017 | - | $1.04 M(-42.6%) |
| Mar 2017 | - | $1.81 M(+31.4%) |
| Dec 2016 | $1.38 M(-26.5%) | $1.38 M(-52.6%) |
| Sept 2016 | - | $2.91 M(-19.1%) |
| June 2016 | - | $3.60 M(+613.3%) |
| Mar 2016 | - | $505.20 K(-90.0%) |
| Dec 2015 | $1.88 M(>+9900.0%) | - |
| Sept 2015 | - | $5.07 M(+15.7%) |
| June 2015 | - | $4.38 M(>+9900.0%) |
| Mar 2015 | - | $3900.00(-23.5%) |
| Dec 2014 | $5100.00(+2450.0%) | $5100.00(-44.0%) |
| Sept 2014 | - | $9100.00(+16.7%) |
| June 2014 | - | $7800.00(-65.3%) |
| Mar 2014 | - | $22.50 K(>+9900.0%) |
| Dec 2013 | $200.00(-85.7%) | $200.00(-71.4%) |
| Sept 2013 | - | $700.00(-70.8%) |
| June 2013 | - | $2400.00(+100.0%) |
| Mar 2013 | - | $1200.00(-14.3%) |
| Dec 2012 | $1400.00(-92.3%) | $1400.00(-33.3%) |
| Sept 2012 | - | $2100.00(-4.5%) |
| June 2012 | - | $2200.00(-63.9%) |
| Mar 2012 | - | $6100.00(-66.5%) |
| Dec 2011 | $18.20 K(+1554.5%) | $18.20 K(-9.9%) |
| Sept 2011 | - | $20.20 K(+431.6%) |
| June 2011 | - | $3800.00(+72.7%) |
| Mar 2011 | - | $2200.00(+100.0%) |
| Dec 2010 | $1100.00 | $1100.00(-73.8%) |
| Sept 2010 | - | $4200.00(+35.5%) |
| June 2010 | - | $3100.00(-67.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2010 | - | $9600.00(+433.3%) |
| Dec 2009 | $1800.00(-97.3%) | $1800.00(-96.1%) |
| Sept 2009 | - | $46.20 K(+244.8%) |
| June 2009 | - | $13.40 K(-62.6%) |
| Mar 2009 | - | $35.80 K(-46.4%) |
| Dec 2008 | $66.80 K(-88.5%) | $66.80 K(-23.5%) |
| Sept 2008 | - | $87.30 K(-8.7%) |
| June 2008 | - | $95.60 K(-93.7%) |
| Mar 2008 | - | $1.53 M(+162.4%) |
| Dec 2007 | $582.00 K(+154.3%) | $582.00 K(-5.2%) |
| Sept 2007 | - | $613.80 K(-24.5%) |
| June 2007 | - | $812.70 K(+11.9%) |
| Mar 2007 | - | $726.30 K(+217.3%) |
| Dec 2006 | $228.90 K(-58.4%) | $228.90 K(-16.2%) |
| Sept 2006 | - | $273.00 K(-8.1%) |
| June 2006 | - | $297.20 K(-15.6%) |
| Mar 2006 | - | $352.30 K(-36.0%) |
| Dec 2005 | $550.60 K(-36.8%) | $550.60 K(-18.4%) |
| Sept 2005 | - | $674.40 K(-7.5%) |
| June 2005 | - | $729.30 K(-16.5%) |
| Mar 2005 | - | $873.90 K(+0.3%) |
| Dec 2004 | $871.20 K(+47.7%) | $871.20 K(-5.3%) |
| Sept 2004 | - | $920.00 K(+147.8%) |
| June 2004 | - | $371.30 K(-42.6%) |
| Mar 2004 | - | $647.10 K(+9.7%) |
| Dec 2003 | $589.80 K(-31.3%) | $589.80 K(-10.2%) |
| Sept 2003 | - | $657.00 K(-16.6%) |
| June 2003 | - | $788.00 K(-11.8%) |
| Mar 2003 | - | $893.60 K(+4.1%) |
| Dec 2002 | $858.70 K(-1.2%) | $858.70 K(-6.3%) |
| Sept 2002 | - | $916.70 K(-5.2%) |
| June 2002 | - | $967.00 K(+10.2%) |
| Mar 2002 | - | $877.80 K(+1.0%) |
| Dec 2001 | $869.50 K(-40.8%) | $869.50 K(+12.7%) |
| Sept 2001 | - | $771.40 K(-18.3%) |
| June 2001 | - | $944.60 K(-34.1%) |
| Mar 2001 | - | $1.43 M(-2.4%) |
| Dec 2000 | $1.47 M(+43.6%) | $1.47 M(-3.3%) |
| Sept 2000 | - | $1.52 M(+0.9%) |
| June 2000 | - | $1.50 M(-12.1%) |
| Mar 2000 | - | $1.71 M(+548.6%) |
| Dec 1999 | $1.02 M(+287.0%) | - |
| Dec 1998 | $264.10 K(-54.3%) | $264.10 K(-12.0%) |
| Sept 1998 | - | $300.00 K(-50.0%) |
| June 1998 | - | $600.00 K(+200.0%) |
| Mar 1998 | - | $200.00 K(-65.4%) |
| Dec 1997 | $577.40 K(-63.6%) | $577.40 K(-27.8%) |
| Sept 1997 | - | $800.00 K(-42.9%) |
| June 1997 | - | $1.40 M(-41.7%) |
| Mar 1997 | - | $2.40 M(+51.2%) |
| Dec 1996 | $1.59 M(-48.8%) | $1.59 M(-45.3%) |
| Sept 1996 | - | $2.90 M(+3.6%) |
| June 1996 | - | $2.80 M(+33.3%) |
| Mar 1996 | - | $2.10 M(-32.3%) |
| Dec 1995 | $3.10 M(+106.7%) | $3.10 M(+72.2%) |
| Dec 1994 | $1.50 M(-16.7%) | - |
| Aug 1994 | - | $1.80 M |
| Aug 1994 | $1.80 M | - |
FAQ
- What is Enveric Biosciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Enveric Biosciences?
- What is Enveric Biosciences annual cash & cash equivalents year-on-year change?
- What is Enveric Biosciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Enveric Biosciences?
- What is Enveric Biosciences quarterly cash and cash equivalents year-on-year change?
What is Enveric Biosciences annual cash & cash equivalents?
The current annual cash & cash equivalents of ENVB is $2.29 M
What is the all time high annual cash & cash equivalents for Enveric Biosciences?
Enveric Biosciences all-time high annual cash & cash equivalents is $17.72 M
What is Enveric Biosciences annual cash & cash equivalents year-on-year change?
Over the past year, ENVB annual cash & cash equivalents has changed by -$15.44 M (-87.09%)
What is Enveric Biosciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ENVB is $3.11 M
What is the all time high quarterly cash and cash equivalents for Enveric Biosciences?
Enveric Biosciences all-time high quarterly cash and cash equivalents is $22.66 M
What is Enveric Biosciences quarterly cash and cash equivalents year-on-year change?
Over the past year, ENVB quarterly cash and cash equivalents has changed by -$1.15 M (-27.07%)